Business · 07/11/2018
FDA Releases Draft Guidance on Meta-Analyses of Clinical Trials for Human Drug Safety
The US Food and Drug Administration (FDA) has made available a draft guidance document outlining the agency's approach to evaluating the safety of human drugs and biological products through meta-analyses of randomized controlled clinical trials.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →